Latest Insider Transactions at Biolife Solutions Inc (BLFS)
This section provides a real-time view of insider transactions for Biolife Solutions Inc (BLFS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BIOLIFE SOLUTIONS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BIOLIFE SOLUTIONS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 12
2021
|
Rachel Ellingson Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+50.0%
|
-
|
|
Apr 12
2021
|
Todd Berard Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,362
+2.88%
|
-
|
|
Apr 12
2021
|
Roderick De Greef President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
3,222
+1.71%
|
-
|
|
Apr 12
2021
|
Michael Rice |
BUY
Grant, award, or other acquisition
|
Direct |
8,487
+3.04%
|
-
|
|
Apr 12
2021
|
Karen A. Foster Chief Quality and Operations |
BUY
Grant, award, or other acquisition
|
Direct |
2,854
+3.73%
|
-
|
|
Apr 12
2021
|
Amy Du Ross Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+50.0%
|
-
|
|
Apr 12
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,360
+1.57%
|
-
|
|
Apr 08
2021
|
Marcus Schulz Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
224
-0.56%
|
$7,840
$35.77 P/Share
|
|
Apr 08
2021
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
11,461
-4.18%
|
$401,135
$35.32 P/Share
|
|
Apr 08
2021
|
Michael Rice |
BUY
Exercise of conversion of derivative security
|
Direct |
11,461
+4.02%
|
$11,461
$1.64 P/Share
|
|
Apr 01
2021
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
10,149
-3.72%
|
$365,364
$36.53 P/Share
|
|
Apr 01
2021
|
Michael Rice |
BUY
Exercise of conversion of derivative security
|
Direct |
26,154
+8.75%
|
-
|
|
Apr 01
2021
|
Roderick De Greef President and CEO |
SELL
Open market or private sale
|
Direct |
3,855
-2.07%
|
$138,780
$36.53 P/Share
|
|
Apr 01
2021
|
Roderick De Greef President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,932
+5.06%
|
-
|
|
Apr 01
2021
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
2,825
-3.53%
|
$101,700
$36.53 P/Share
|
|
Apr 01
2021
|
Todd Berard Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,279
+8.34%
|
-
|
|
Apr 01
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
4,020
-1.96%
|
$144,720
$36.53 P/Share
|
|
Apr 01
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,358
+4.67%
|
-
|
|
Apr 01
2021
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
3,414
-4.6%
|
$122,904
$36.53 P/Share
|
|
Apr 01
2021
|
Karen A. Foster Chief Quality and Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
8,797
+10.6%
|
-
|
|
Mar 26
2021
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
2,120
-2.83%
|
$74,200
$35.01 P/Share
|
|
Mar 26
2021
|
Roderick De Greef President and CEO |
SELL
Open market or private sale
|
Direct |
2,893
-1.62%
|
$101,255
$35.01 P/Share
|
|
Mar 26
2021
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
3,809
-1.52%
|
$133,315
$35.01 P/Share
|
|
Mar 26
2021
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
2,562
-3.77%
|
$89,670
$35.01 P/Share
|
|
Mar 26
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,016
-1.48%
|
$105,560
$35.01 P/Share
|
|
Mar 25
2021
|
Roderick De Greef President and CEO |
SELL
Open market or private sale
|
Direct |
10,000
-5.29%
|
$370,000
$37.71 P/Share
|
|
Mar 25
2021
|
Roderick De Greef President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+5.02%
|
$10,000
$1.81 P/Share
|
|
Mar 24
2021
|
Roderick De Greef President and CEO |
SELL
Open market or private sale
|
Direct |
10,000
-5.29%
|
$400,000
$40.18 P/Share
|
|
Mar 24
2021
|
Roderick De Greef President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+5.02%
|
$10,000
$1.81 P/Share
|
|
Mar 24
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-4.67%
|
$400,000
$40.18 P/Share
|
|
Mar 24
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+4.46%
|
$10,000
$1.64 P/Share
|
|
Mar 23
2021
|
Roderick De Greef President and CEO |
SELL
Open market or private sale
|
Direct |
10,000
-5.29%
|
$410,000
$41.83 P/Share
|
|
Mar 23
2021
|
Roderick De Greef President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+5.02%
|
$10,000
$1.81 P/Share
|
|
Mar 22
2021
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
16,332
-19.37%
|
$604,284
$37.56 P/Share
|
|
Mar 22
2021
|
Karen A. Foster Chief Quality and Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
16,332
+16.23%
|
$16,332
$1.64 P/Share
|
|
Mar 22
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-4.67%
|
$370,000
$37.8 P/Share
|
|
Mar 22
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+4.46%
|
$10,000
$1.64 P/Share
|
|
Mar 16
2021
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
6,160
-7.6%
|
$221,760
$36.72 P/Share
|
|
Mar 16
2021
|
Todd Berard Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,160
+7.07%
|
$6,160
$1.64 P/Share
|
|
Mar 15
2021
|
Andrew G Hinson Director |
SELL
Open market or private sale
|
Direct |
2,500
-7.66%
|
$92,500
$37.32 P/Share
|
|
Mar 15
2021
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
6,160
-7.6%
|
$221,760
$36.91 P/Share
|
|
Mar 15
2021
|
Todd Berard Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,160
+7.07%
|
$6,160
$1.64 P/Share
|
|
Feb 26
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
403
-0.2%
|
$15,717
$39.57 P/Share
|
|
Feb 26
2021
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
284
-0.42%
|
$11,076
$39.57 P/Share
|
|
Feb 26
2021
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
861
-0.34%
|
$33,579
$39.57 P/Share
|
|
Feb 22
2021
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
16,334
-19.31%
|
$637,026
$39.66 P/Share
|
|
Feb 22
2021
|
Karen A. Foster Chief Quality and Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
16,334
+16.18%
|
$16,334
$1.64 P/Share
|
|
Feb 19
2021
|
Roderick De Greef President and CEO |
SELL
Open market or private sale
|
Direct |
4,509
-2.46%
|
$180,360
$40.76 P/Share
|
|
Feb 19
2021
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
1,876
-2.44%
|
$75,040
$40.76 P/Share
|
|
Feb 19
2021
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
10,107
-3.87%
|
$404,280
$40.76 P/Share
|